Parallel Pancreatic Cancer Chemotherapy Cuts Infusion Time but Safety Remains Uncertain
Parallel administration of nanoliposomal irinotecan and levofolinate reduced daily bed occupancy by approximately 150 minutes, though comparative safety estimates remained ...

